OWC Pharmaceutical Research Corp. (OWCP)

"Transforming cannabis into scientifically proven and clinically approved medical solutions"

U.S. Patent 10,603,301 Issued March 31, 2020 - Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders

-- NATIONAL INSTITUTE OF HEALTH CLINICAL TRIALS --

OWC Pharmaceutical Research Corp. (OWCP)
A Delaware Corporation since March 6, 2008

11 Anne Frank Street
Petah Tikva, Israel 4931113

IR@OWCPHARMA.COM
 

OWC Pharmaceutical Research Corp. is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd. ("OWC"), of conducting
medical research and clinical trials, in full compliance with all international regulatory protocols, for the development and improvement of strains of medical cannabis
specifically designed for the treatment of several illnesses/medical conditions including Multiple Myeloma, Psoriasis, Fibromyalgia, Migraine, and PTSD.

 Our business plan includes entering into collaborative ventures with major medical centers and highly regarded researchers in Israel and potentially
other countries with the goal of developing novel therapeutic methods for the treatment of serious medical conditions with cannabis-based therapies and are
conducting pre-clinical investigations and randomized, placebo-controlled trials of cannabis-based compounds and develop unique, condition-specific products.
 

-- Leadership Team -- Ziv Turner Chairman and CEO Ziv's Private Cannabis Businesses Cannible The PeliCann Shmuel De-Saban CFO and Board Member Dr. Med Yehuda Baruch Chief Medical & Regulatory Officer ADVISORY BOARD Amir Ohad - Financial Advisor Zvi Riterband - Financial Advisor Dr. Gila Shimoni - Patent Advisor

-- Research --
 

--Intellectual Property--

ALL PUBLISHED PATENT APPLICATIONS NAME ONE WORLD CANNABIS AS THE ASSIGNEE (OWNER)

OWCP's Intellectual Property Portfolio comprises 9 patent families and includes 31 filings in selected domains at various stages from PCT filings, National Phase filings
and Continuations in Part (CIP).  The National Phase is the second of the two main phases of the Patent Cooperation Treaty (PCT) procedure. It follows the international phase and consists
of the processing of the international application before each office of or acting for a contracting state of the PCT that has been designated in the international application.
The table below will be updated when the  unknown patent families and additional patent applications are identified.

RICHTER & SHIMONI
OWC's main Patent Agency located in Israel, Germany and Switzerland
Richter engages patent lawyers in other domains for filing purposes
Dr. Gila Shimoni is primary author/editor of patent application content

BROWDY & NEIMARK'S WEBSITE (USPTO)
Browdy is OWC's U.S. Intellectual Property Law Firm

DENNEMEYER & CO. WEBSITE (AUSPAT)
Chronic Pain - Emulsions
ACTIONS TAKEN WITHIN PAST 30 DAYS

     AUSPAT (Australia) (AU)     Canadian Intellectual Property Office (CA)    Czech IPO (CZ)    European Patent Register (EPR)    Israel Patent Office (IL)     US Patent & Trademark Office (USPTO)       WIPO Patentscope (WIPO)
To search for USPTO Patent records, enter the Application Number in the search field.  View documents under Image File Wrapper tab.  To download, check the box in far right column, then click on PDF button above it.

*The Psoriasis agreement with Sheba Academic Medical Center provides that all intellectual property that is conceived during the course of the research is to be jointly owned by Sheba and One World Cannabis.

-- ACTIVE LITIGATION --

OWC Pharmaceutical Research Corp is the Plaintiff in both cases filed in Supreme Court of New York County.
Link to Filings